Mohammad Mehdi Akbarin

Dr. Mohammad Mehdi Akbarin


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HTHanieh Tarokhian
Hanieh Tarokhian
HRHossein Rahimi
Hossein Rahimi
AMArman Mosavat
Arman Mosavat
ASAbbas Shirdel
Abbas Shirdel
HRHoushang Rafatpanah
Houshang Rafatpanah
SASeyed Abdolrahim Rezaee
Seyed Abdolrahim Rezaee
Adult T-cell leukemia/lymphoma (ATLL) is a lymphoproliferative disorder of HTLV-1-host interactions in infected TCD4+ cells. In this study, the HTLV-1 proviral load (PVL) and HBZ as viral elements and AKT1, BAD, FOXP3, RORγt and IFNλ3 as the host factors were investigated. The study was conducted in ATLLs, HTLV-1-associated myelopathy/tropical spastic paraparesis patients (HAM/TSPs) and HTLV-1-asympthomatic carriers (ACs). The DNA and mRNA from peripheral blood mononuclear cells were extracted for gene expression assessments via qRT-PCR, TaqMan assay, and then confirmed by western blotting. As it was expected, the HTLV-1-PVL were higher in ATLLs than ACs (P = 0.002) and HAM/TSP (P = 0.041). The HBZ expression in ATLL (101.76 ± 61.3) was radically higher than in ACs (0.12 ± 0.05) and HAM/TSP (0.01 ± 0.1) (P = 0.001). Furthermore, the AKT1 expression in ATLLs (13.52 ± 4.78) was higher than ACs (1.17 ± 0.27) (P = 0.05) and HAM/TSPs (0.72 ± 0.49) (P = 0.008). However, BAD expression in ATLL was slightly higher than ACs and HAM/TSPs and not significant. The FOXP3 in ATLLs (41.02 ± 24.2) was more than ACs (1.44 ± 1) (P = 0.007) and HAM/TSP (0.45 ± 0.15) (P = 0.01). However, RORγt in ATLLs (27.43 ± 14.8) was higher than ACs (1.05 ± 0.32) (P = 0.02) but not HAM/TSPs. Finally, the IFNλ3 expression between ATLLs (31.92 ± 26.02) and ACs (1.46 ± 0.63) (P = 0.01) and ACs and HAM/TSPs (680.62 ± 674.6) (P = 0.02) were statistically different, but not between ATLLs and HAM/TSPs. The present and our previous study demonstrated that HTLV-1-PVL and HBZ and host AKT1 and Rad 51 are novel candidates for molecular targeting therapy of ATLL. However, high level of RORγt may inhibit Th1 response and complicated in ATLL progressions.

7 June 2022 in Microbial Pathogenesis
Verified
Journal Article
Closed access
SRSamaneh Ramezani
Samaneh Ramezani
SASeyed Abdolrahim Rezaee
Seyed Abdolrahim Rezaee
ZFZahra Farjami
Zahra Farjami
NENeshat Ebrahimi
Neshat Ebrahimi
HAHasaneen Kudhair Abdullabass
Hasaneen Kudhair Abdullabass
MAMohammad Mehdi Akbarin
Mohammad Mehdi Akbarin

4 September 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
AGAna Silvia González-Méndez
Ana Silvia González-Méndez
MAMohammad Mehdi Akbarin
Mohammad Mehdi Akbarin
FCFernando Cerón-Téllez
Fernando Cerón-Téllez
GAGabriel Eduardo Acevedo-Jiménez
Gabriel Eduardo Acevedo-Jiménez
CRCecilia Rodríguez-Murillo
Cecilia Rodríguez-Murillo
Hugo Ramírez ÁlvarezHugo Ramírez Álvarez
Hugo Ramírez Álvarez
Introduction: Bovine leukemia virus is a single-stranded RNA virus that targets B cell CD5+ lymphocytes in cattle. Only a tiny percentage of individuals develop malignant lymphoproliferative disorders, while most remain healthy carriers or experience persistent lymphocytosis. The exact mechanisms leading to lymphoma development are complex and not fully understood. RNA-seq analysis of cows’ peripheral blood leukocytes (PBLs) with and without Bovine leukemia virus (BLV) antibodies was conducted to gain a deeper understanding of molecular events beyond BLV infection. Method: Eighteen samples were selected, and their RNA was sequenced. For gene expression analysis and protein–protein network interactions, three groups were selected, including healthy negative samples (CT, n = 7), asymptomatic carriers (AC, n = 5), and persistent lymphocytosis (PL, n = 6), to provide the differentially expressed gene (DEG) and protein–protein interaction network (PPIN) outputs. Results: Our results demonstrated that in comparison to CT, ACs upregulated TLR7 and transcription activation factors. In the CT vs. PL group, MHC class II, transcription activation factors, and anti-inflammatory cytokines increased, while the acute-phase proteins, antiviral receptors, and inflammatory cytokines decreased. Additionally, antiviral receptors, acute-phase proteins, and inflammatory receptors were downregulated in the PL versus the AC groups. Moreover, PPINs analysis suggested that nuclear receptor corepressor 1 (NCOR1), serine/arginine repetitive matrix 2 (SRRM2), LUC7 like 3 pre-mRNA splicing factor (LUC7L3), TWIST neighbor (TWISTNB), U6 small nuclear RNA and mRNA degradation associated (LSM4), eukaryotic translation elongation factor 2 (EEF2), ubiquitin C (UBC), CD74, and heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNP A2B1) are possible hub gene candidates in the PL group. Conclusions: Our results suggest that innate and cellular immune responses are more loose in severe BLV infectious conditions, while the PPINs revealed that new protein interactions are necessary for oncogenesis.

1 March 2024 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
ZFZahra Farjami
Zahra Farjami
MAMohammad Mehdi Akbarin
Mohammad Mehdi Akbarin
HRHoushang Rafatpanah
Houshang Rafatpanah
SRSamaneh Ramezani
Samaneh Ramezani
HRHossein Rahimi
Hossein Rahimi
SASeyed Abdolrahim Rezaee
Seyed Abdolrahim Rezaee
Introduction: Adult T-cell leukemia/lymphoma is a malignancy with a poor prognosis caused by HTLV-1 infection. TAX and HBZ are two major viral proteins that may be involved in oncogenesis by disrupting apoptosis. Because Bcl-xL plays an integral role in the anti-apoptotic pathway, this study examines the interaction between host apoptosis and oncoproteins. Method and Material: We investigated 37 HTLV-1-infected individuals, including 18 asymptomatic and 19 ATLL subjects. mRNA was extracted and converted to cDNA from peripheral blood mononuclear cells (PBMCs), and then gene expression was determined using TaqMan qPCR. Moreover, the HTLV-I proviral load was also measured using a commercial absolute quantification kit (Novin Gene, Iran). Results: Data analysis revealed that the mean of TAX, HBZ, and PVL was significantly higher among the study groups (ATLL and carriers groups P= (0.003), P= (0.000), and P= (0.002) respectively). There was no statistical difference in Bcl-xL gene expression between studies groups (P=0.323). Conclusion: It is proposed that this anti-apoptotic pathway may not be directly involved in the development of ATLL lymphoma. TAX, HBZ gene expression, and PVL can be utilized as prognostic markers. Keywords: HTLV-1, ATLL, HBZ, TAX, Bcl-xL, Apoptosis

3 March 2026 in Medical Oncology
Verified
Journal Article
Open access
ZFZahra Farjami
Zahra Farjami
MAMohammad Mehdi Akbarin
Mohammad Mehdi Akbarin
Deltaretroviruses, including Human T-cell Leukemia Virus type 1 (HTLV-1) and Bovine Leukemia Virus (BLV), are oncogenic pathogens that exploit host transcriptional machinery to establish persistence and drive malignant transformation. Central to this process is the cAMP response element-binding protein (CREB), a transcription factor that regulates cell survival, proliferation, and differentiation. Viral proteins, such as Tax and HBZ, directly interact with CREB and its cofactors (CBP/p300, TORC2), enabling the robust activation of viral long terminal repeats (LTRs) and the dysregulation of host gene expression, including key regulators of apoptosis and the cell cycle. CREB phosphorylation and complex assembly with Tax and cofactors are critical steps in sustaining viral replication, anti-apoptotic signaling, and oncogenesis. Comparative studies highlight conserved roles of CREB in both HTLV-1 and BLV, where it not only mediates viral transcription but also contributes to immune evasion, genomic instability, and malignant progression. Epigenetic modulation and cellular factors, such as c-Maf and MEF-2, further refine CREB-dependent transcriptional outcomes, underscoring the intricate interplay between virus and host. Importantly, clinical data from patients with Adult T-cell Leukemia/Lymphoma (ATLL) show CREB overexpression and a correlation with viral gene expression, reinforcing its role in disease progression. Collectively, these findings establish CREB as a central hub in deltaretrovirus biology and pathogenesis. Targeting CREB signaling may therefore represent a promising therapeutic strategy for controlling both HTLV-1 and BLV-associated malignancies. This review integrates current knowledge of CREB's role in deltaretrovirus infection and highlights its potential as a therapeutic target for future antiviral and anticancer interventions.

31 December 2025 in Viral Immunology
Verified
Journal Article
Closed access
ZFZahra Farjami
Zahra Farjami
MMMina Moradi
Mina Moradi
NENeshat Ebrahimi
Neshat Ebrahimi
MAMohammad Mehdi Akbarin
Mohammad Mehdi Akbarin
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.